Myocarditis

Revision as of 20:08, 25 June 2025 by Patricklin (talk | contribs)

This page is for adult patients. For pediatric patients, see: myocarditis (peds)

Background

Triggers of myocarditis. Myocarditis can be induced by both infectious and non-infectious pathogens, with viral infection being the most common cause (red background).
  • Inflammatory cardiomyopathy caused by damage and necrosis of myocytes
    • Viral-induced is the most common etiology[1]
  • Clinical presentation ranges from smoldering heart failure to fulminant cardiogenic shock or sudden death
  • Maintain a high index of suspicion in younger patients without traditional CAD risk factors

Causes

Phases

  • Acute
    • Direct cytotoxicity and focal necrosis from viral, autoimmune, or toxins
  • Subacute
    • Host's humoral/immune response (viral molecular mimicry and anti-myocyte antibody production) leading to further cell injury
  • Chronic
    • Diffuse myocardial fibrosis and cardiac dysfunction

Clinical Features


Differential Diagnosis

Consider other causes of CHF

Chest pain

Critical

Emergent

Nonemergent

Evaluation

Diffuse ST elevation in a patient with combined myocarditis and pericarditis.

Management

  • Acute phase
    • Antiviral agents (Pleconaril/Ribavirin) may be effective
    • COVID-related: limited/conflicting evidence regarding efficacy of high-dose steroids and/or IVIG [3]
  • Subacute phase
    • Studies have not shown efficacy of immunosupressants
    • Pediatric patients may receive high-dose IVIG
  • Chronic phase
    • Treatment for CHF symptoms
    • Ventricular Assist Devices (VAD)
    • Cardiac transplant

Disposition

  • If CHF is present, admit to monitored bed
  • If hemodynamically unstable, admit to ICU

Prognosis

  • Fulminant myocarditis has best prognosis
  • Mortality: 20% 1 yr/ 50% 5 yr
  • Children with 70% survival rate at 5 yrs

Complications

See Also

External Links

References